Pharmaceuticals
Growth Hormone Deficiency Treatment Market

Growth Hormone Deficiency Treatment Market

Growth Hormone Deficiency Treatment Market: Global Industry Analysis and Forecast 2016 - 2022

ID: PMRREP9962

Upcoming

Author : Abhijeet Surwase

Introduction

Growth hormone deficiency (GHD) is a medical condition characterized by insufficient production of somatropin, a growth hormone, from the anterior pituitary gland which is responsible for the growth and cell reproduction. Though the exact cause of growth hormone deficiency is obscure, it is considered to be of genetic origin or also it can develop after a trauma, brain injury, due to pituitary tumors etc.

Children with growth hormone deficiency show retarded growth and sometimes delayed puberty. Symptoms of growth hormone deficiency vary among adults and children.

The predominant symptom in children is that the child is abnormally shorter than other children of his age with or without compromise in the cognitive intelligence while in adults, growth hormone deficiency may lead to fatigue, tiredness, anxiety and depression. Growth hormone deficiency is treated with growth hormone injections on daily or weekly basis although the effects of therapy starts showing after 2-3 months of therapy.

The primary factor contributing to the growth of global growth hormone deficiency treatment market is increasing incidence of growth hormone deficiency syndrome.

Several other factors which may cause the global growth hormone deficiency market to grow include changing lifestyle, prevalence of other genetic disorders and incidence of GHD in adults. However, high cost of treatment will always remain the major restraint for global growth hormone deficiency treatment market.